12th Jun 2014 10:37
LONDON (Alliance News) - Shares in Tissue Regenix Group PLC were up by almost a quarter Thursday after it announced the launch of its DermaPure wound-healing product in the US, and said it has expanded its distribution network in the US.
Shares in Tissue Regenix were trading up 24% at 25.34 pence Thursday morning.
The company's US partner, Community Tissue Services, will begin shipping the skin substitute to customers next week. Separately, Tissue Regenix has signed an exclusive government-supplier partnership with US-based healthcare provider TASSMA LLC for the distribution of DermaPure.
The product works by taking donor skin and removing DNA and cells using the company's dCELL process to leave a natural scaffold that can be placed in the wound and aid natural healing.
Tissue Regenix will also continue to promote its product in acute care hospitals, Veteran Affairs hospitals and institutions and Long Term Acute Care hospitals via its network of 60 US sales representatives.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Tissue Regenix Group